Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2019 |
Sep. 30, 2018 |
Sep. 30, 2019 |
Sep. 30, 2018 |
||||||
Revenue: | |||||||||
Revenue from contract with customer | $ 5,000 | $ 22,000 | $ 35,000 | $ 303,000 | |||||
Grant and other revenue | 231,916 | 209,146 | 514,589 | 762,549 | |||||
Revenues, Total | 236,811 | 231,458 | 538,527 | 1,050,030 | |||||
Cost of revenue | 195 | 38,101 | 6,559 | 73,811 | |||||
Gross profit | 236,616 | 193,357 | 531,968 | 976,219 | |||||
Operating expenses: | |||||||||
Research and development | 1,801,558 | 1,225,770 | 3,612,783 | 3,367,444 | |||||
Selling, general and administrative | 1,519,496 | 2,688,703 | 5,109,612 | 6,254,474 | |||||
Total operating expenses | 3,321,054 | 3,914,473 | 8,722,395 | 9,621,918 | |||||
Loss from operations | [1] | (3,084,438) | (3,721,116) | (8,190,427) | (8,645,699) | ||||
Other income (expense): | |||||||||
Interest income (expense), net | 11,858 | (28,074) | 23,336 | (20,234) | |||||
Loss on extinguishment of debt | (4,265,434) | ||||||||
Other, net | (1,524) | 3,540 | (5,880) | 1,654 | |||||
Total other income (expense), net | [2] | 10,334 | (24,534) | 17,456 | (4,284,014) | ||||
Loss before income taxes | (3,074,104) | (3,745,650) | (8,172,971) | (12,929,713) | |||||
Provision for income taxes | (76,259) | (707) | (65,330) | ||||||
Loss from continuing operations | (3,074,104) | (3,821,909) | (8,173,678) | (12,995,043) | |||||
Loss from discontinued operations | (2,665) | (1,938) | |||||||
Gain on sale | 43,053 | ||||||||
Net loss | (3,074,104) | (3,821,909) | (8,176,343) | (12,953,928) | |||||
Less loss attributable to noncontrolling interest | (2) | (308) | (16) | (333) | |||||
Net loss attributable to common stockholders | $ (3,074,102) | $ (3,821,601) | $ (8,176,327) | $ (12,953,595) | |||||
Loss per common share (basic and diluted): | |||||||||
Continuing operations (in dollars per share) | $ (0.17) | $ (0.46) | $ (0.62) | $ (1.59) | |||||
Discontinued operations (in dollars per share) | 0.01 | ||||||||
Attributable to common stockholders (in dollars per share) | $ (0.17) | $ (0.46) | $ (0.62) | $ (1.58) | |||||
Weighted average shares outstanding (in shares) | 18,044,406 | 8,342,771 | 13,082,393 | 8,198,197 | |||||
Royalty [Member] | |||||||||
Revenue: | |||||||||
Revenue from contract with customer | $ 4,895 | $ 2,382 | $ 13,985 | $ 9,842 | |||||
License [Member] | |||||||||
Revenue: | |||||||||
Revenue from contract with customer | $ 19,930 | $ 9,953 | $ 277,639 | ||||||
|
X | ||||||||||
- Definition Represents the amount of grant and other revenue recorded during the period. No definition available.
|
X | ||||||||||
- Definition Represents the amount of nonoperating income (expense) recorded during , including equity method investments. No definition available.
|
X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount after tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until disposal. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Per basic and diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation, when the per share amount is the same. No definition available.
|
X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|